Fuchs’ Endothelial Corneal Dystrophy (FECD) Genetics Study

Study Overview
Minnesota Eye Consultants has been funded by the National Institutes of Health to study the genetics of Fuchs’ Endothelial Corneal Dystrophy, also known as FECD. In addition to recruiting FECD-affected patients, control participants (patients not affected with FECD) are also asked to enroll in this study. The findings from this study may lead to methods for detection of the disease at an earlier stage and may also aid in treatment and possible prevention of FECD.

Control Patients:
Control patients need to be 70 years of age or older and free of any corneal abnormalities or disease.

Affected Patients:
Affected patients must be diagnosed with FECD and must have either had a corneal transplant or are scheduled to undergo a corneal transplant.

What will participants need to do?
Participants will have a comprehensive eye examination performed by a Minnesota Eye Consultants ophthalmologist or optometrist. They will also have a blood draw and be asked to provide basic medical information about themselves as well as family members.

Is there a cost to participate?
There is no cost to participants. The comprehensive eye examination for this study will be provided at no charge. However, if the doctor determines that other tests are needed due to other eye conditions unrelated to this study, those tests will be billed to you and/or your insurance company.

How will you benefit?
There may be no direct benefit to you as a participant in this research study. However, it is hoped that participation may lead to earlier diagnosis and treatment of FECD.

How to find out more:
For more information about the study and to learn how to participate, you can contact the Minnesota Eye Consultants’ Clinical Research Department at (612) 813-3607.